Search Results - "Fahad Almohareb"

An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 by Al-Harbi, Sayer, Aljurf, Mahmoud, Mohty, Mohamad, Almohareb, Fahad, Ahmed, Syed Osman Ali

“…Acute myeloid leukemia (AML) with t(8;21)(q22;q22.1);RUNX1-RUNX1T1, one of the core-binding factor leukemias, is one of the most common subtypes of AML with…”
Get full text

Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease by Cappelli, Barbara, Volt, Fernanda, Tozatto-Maio, Karina, Scigliuolo, Graziana Maria, Ferster, Alina, Dupont, Sophie, Simões, Belinda Pinto, Al-Seraihy, Amal, Aljurf, Mahmoud D, Almohareb, Fahad, Belendez, Cristina, Matthes, Susanne, Dhedin, Nathalie, Pondarre, Corinne, Dalle, Jean-Hugues, Bertrand, Yves, Vannier, Jean Pierre, Kuentz, Mathieu, Lutz, Patrick, Michel, Gérard, Rafii, Hanadi, Neven, Benedicte, Zecca, Marco, Bader, Peter, Cavazzana, Marina, Labopin, Myriam, Locatelli, Franco, Magnani, Alessandra, Ruggeri, Annalisa, Rocha, Vanderson, Bernaudin, Françoise, de La Fuente, Josu, Corbacioglu, Selim, Gluckman, Eliane

Get full text

Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission by Haroon, Alfadil, Alfraih, Feras, Hanbali, Amr, Kotb, Ahmed, Somali, Zakiah Al, Bahkali, Fahad N., Alhayli, Saud, Madien, Heba Mahmoud, Ahmed, Syed Osman, Albabtain, Abdulwahab A., Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Alshaibani, Alfadel, Alotaibi, Ahmad S., Elhassan, Tusneem, Almohareb, Fahad, Alahmari, Ali, Rasheed, Walid, Alzahrani, Hazzaa, Aljurf, Mahmoud, El Fakih, Riad

“…Background Pediatric-inspired non-transplant regimens for adolescent and adult ALL patients are becoming standard in many institutions. We aimed to compare a…”
Get full text

Frontline-matched sibling donor transplant of aplastic anemia patients using primed versus steady-state bone marrow grafts by El Fakih, Riad, Alfraih, Feras, Alhayli, Saud, Ahmed, Syed Osman, Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Hanbali, Amr, Alshaibani, Alfadel, Alotaibi, Ahmad S., Alharbi, Bander, AlYahya, Faisal Mohammed, Rawas, Wedian M., Ghabashi, Emad, Kotb, Ahmed, Elhassan, Tusneem, Rasheed, Walid, Alzahrani, Hazzaa, Almohareb, Fahad, Alahmari, Ali, Aljurf, Mahmoud

“…Priming donors with G-CSF before BM harvest is reported to improve engraftment and GvHD in recipients. These effects are highly desirable when transplanting…”
Get full text

Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patients by El Fakih, Riad, Kotb, Ahmed, Hashmi, Shahrukh, Chaudhri, Naeem, Alsharif, Fahad, Shaheen, Marwan, Alshomar, Ahmad, Hanbali, Amr, Alfraih, Feras, Alhayli, Saud, Albarqi, Hussein, Alnefaie, Budur, Elhassan, Tusneem, Alsadi, Husam, Youniss, Riad, Alahmari, Ali, Rasheed, Walid, Alzahrani, Hazzaa, Almohareb, Fahad, Ahmed, Syed, Aljurf, Mahmoud

“…Patients between 14 and 22 years old are underrepresented in both adult and pediatric studies. We analyzed the outcomes of 94 consecutive patients aged between…”
Get full text

OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY by Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, Saud Alhayli, Marwan Shaheen, Abdulwahab Albabtain, Fahad Alsharif, Feras Alfraih, Walid Rasheed, Mahmoud Aljurf

“…Objective Background: Aplastic anemia is pancytopenia with a hypocellular bone marrow [<25 % (or 25 to 50 % if <30 % of residual cells are hematopoietic)] due…”
Get full text

Posterior reversible encephalopathy syndrome post stem cell transplantation in sickle cell disease: case series and literature review by BinAmir, Hussain A, AlAhmari, Ali, AlQahtani, AlWaleed, Mohamed, Gamal, Alotaibi, Fawaz, AlShamrani, Mohamed, AlSaeed, Ali, AlGhanmi, Suwaidi, Heji, Alaa, Alreshaid, Abdulrahman, AlKawi, Ammar, AlHazzani, Adel, AlZawahmah, Mohamed, Shuaib, Ashfaq, Al-Ajlan, Fahad, AlMohareb, Fahad

“…Posterior reversible encephalopathy syndrome (PRES) is a serious neurological syndrome that may develop following immunosuppressive therapy for stem cell…”
Get full text

Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group by Mohammed, Jaleel, Aljurf, Mahmoud, Althumayri, Abdulaziz, Almansour, Muntaha, Alghamdi, Ahmed, Hamidieh, Amir Ali, ElHaddad, Alaa, Othman, Tarek Ben, Bazarbachi, Ali, Almohareb, Fahad, Alzahrani, Mohsen, Alkindi, Salam S., Alsharif, Fahad, Da'na, Waleed, Alhashmi, Hani, Bekadja, Mohamed A., Al-Shammari, Salem H., El Quessar, Asma, Satti, Tariq M., Aljohani, Naif, Rasheed, Walid, Ghavamzadeh, Ardeshir, Chaudhri, Naeem, Hashmi, Shahrukh K.

“…Patients undergoing hematopoietic stem cell transplantation (HSCT) are often referred for physical therapy (PT) to help improve their quality of life. However,…”
Get full text

P1420: COMPARATIVE STUDY OF CYCLOSPORINE VERSUS TACROLIMUS IN ADDITION TO METHOTREXATE AS GRAFT VERSUS HOST DISEASE PROPHYLAXIS IN MATCHED SIBLING ALLOGENEIC STEM CELL TRANSPLANTATION OF SICKLE CELL DISEASE by Alfaqawi, Samar, Mohammed Saleh, Mostafa, Kotb, Ahmed, Abdallah, Ghada, Ali, Leena, Alasbali, Reem, Hussain, Taimor, Alfadhil, Haroon, Bin Salman, Ahmed, Nassani, Momen, Baujaifer, Yazeed, Sharif, Mohammed I., Nassar, Marwa, Samarkandi, Sarah, Madien, Heba, Hejab, Amal, Alyamany, Ruah, Alnughmush, Ahmed, Alamer, Abdullah, Saad, Ayman, Alfayez, Mansour, Albabtain, Abdelwahab, Alshaibani, Alfadel, Alotaibi, Ahmad, Alhayli, Saud, Shaheen, Marwan, Ahmed, Syed O., Elfakih, Riad, Hanbali, Amr, Alfraih, Feras, Rasheed, Walid, Alsharif, Fahad, Chaudhri, Naeem, Alzahrani, Hazza, Almohareb, Fahad, Aljurf, Mahmoud, Alahmari, Ali

Get full text

Comprehensive multi-omics analysis of G6PC3 deficiency-related congenital neutropenia with inflammatory bowel disease by Dasouki, Majed, Alaiya, Ayodeele, ElAmin, Tanziel, Shinwari, Zakia, Monies, Dorota, Abouelhoda, Mohamed, Jabaan, Amjad, Almourfi, Feras, Rahbeeni, Zuhair, Alsohaibani, Fahad, Almohareb, Fahad, Al-Zahrani, Hazzaa, Guzmán Vega, Francisco J., Arold, Stefan T., Aljurf, Mahmoud, Ahmed, Syed Osman

“…Autosomal recessive mutations in G6PC3 cause isolated and syndromic congenital neutropenia which includes congenital heart disease and atypical inflammatory…”
Get full text

The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities by Hassanein, Mona, Fakih, Riad El, Rasheed, Walid, Ahmed, Syed, Shaheen, Marwan, Chaudhri, Naeem, Alsharif, Fahad, Ahmed, Shad, Hanbali, Amr, AlShaibani, Alfadel, Alfraih, Feras, Alhayli, Saud, Elhassan, Tusneem, Alahmari, Ali, Alzahrani, Hazzaa, Almohareb, Fahad, Aljurf, Mahmoud, Hashmi, Shahrukh

“…Secondary acute myeloid leukemia (sAML) includes AML as a complication of an antecedent hematological disorder or a therapy‐related AML. Large registry‐based…”
Get full text

Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies by Chaudhri, Naeem A., Aljurf, Mahmoud, Almohareb, Fahad I., Alzahrani, Hazzaa A., Bashir, Qaiser, Savani, Bipin, Gupta, Vikas, Hashmi, Shahrukh K.

“…More than 70,000 hematopoietic cell transplants are currently performed each year, and these continue to increase every year. However, there is a significant…”
Get full text

Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center by Hanbali, Amr, Kotb, Ahmed, Fakih, Riad El, Alfraih, Feras, Ahmed, Syed Osman, Shaheen, Marwan, Alhayli, Saud, Alahmari, Ali, Alotaibi, Ahmad, Alshaibani, Alfadel, Riash, Mahmoud Abu, Deeba, Farah, Asif, Maryam, Rasheed, Walid, Alzahrani, Hazzaa, Alsharif, Fahad, Chaudhri, Naeem, Almohareb, Fahad, Aljurf, Mahmoud

“…Treating adolescents and young adults (AYA) patients with acute lymphoblastic leukemia (ALL) using pediatric-inspired protocols have shown improvement in…”
Get full text

Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes by Alhashim, Noura, Aljurf, Mahmoud, Hassanein, Mona, Chaudhri, Naeem, Hashmi, Shahrukh, El-Gohary, Ghada, Alsharif, Fahad, Alsermani, Maamoun, Alhumaid, Muhned, Beihany, Amal Al, Shaheen, Marwan, Hanbali, Amr, Alfraih, Feras, Mohamed, Said, Alzahrani, Hazzaa, Elhassan, Tusneem, Eldali, Abdelmoneim, Rasheed, Walid, Ahmed, Syed, Almohareb, Fahad, El Fakih, Riad

Get full text

Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population by Monies, Dorota, Abouelhoda, Mohammed, Assoum, Mirna, Moghrabi, Nabil, Rafiullah, Rafiullah, Almontashiri, Naif, Alowain, Mohammed, Alzaidan, Hamad, Alsayed, Moeen, Subhani, Shazia, Cupler, Edward, Faden, Maha, Alhashem, Amal, Qari, Alya, Aldhalaan, Hisham, Kurdi, Wesam, Khan, Sameena, Rahbeeni, Zuhair, Goljan, Ewa, Elbardisy, Hadeel, ElKalioby, Mohamed, Shah, Zeeshan, Jaafar, Amal, Albar, Ranad, Akilan, Asma, Tayeb, Hamsa, Tahir, Asma, Fawzy, Mohammed, Nasr, Mohammed, Makki, Shaza, Alfaifi, Abdullah, Akleh, Hanna, Yamani, Suad, Bubshait, Dalal, Mahnashi, Mohammed, Basha, Talal, Alsagheir, Afaf, Alsaleem, Khalid, Badawi, Manal, Bashiri, Fahad, Bohlega, Saeed, Tous, Ehab, Ahmed, Syed, Algoufi, Talal, Al-Mousa, Hamoud, Alaki, Emadia, Alhumaidi, Susan, Alghamdi, Hadeel, Alghamdi, Malak, Sahly, Ahmed, Al-Ahmari, Ali, Alkuraya, Hisham, Almehaidib, Ali, Abanemai, Mohammed, Alsohaibaini, Fahad, Arnaout, Rand, Abdel-Salam, Ghada M.H., Aldhekri, Hasan, AlKhater, Suzan, Alqadi, Khalid, Alshareef, Turki, Banjar, Hanaa, Alsahan, Nada, Abosoudah, Ibraheem, Alashwal, Abdullah, Alhajjar, Sami, Al-Mayouf, Sulaiman, Alsemari, Abdulaziz, Alshuaibi, Walaa, Altala, Saeed, Baz, Salah, Hamad, Muddathir, Abalkhail, Tariq, Alenazi, Badi, Alkaff, Alya, Almohareb, Fahad, Al Mutairi, Fuad, Alsaleh, Mona, Alzelaye, Somaya, Bahzad, Shakir, Manee, Abdulaziz Bin, Jarrad, Ola, Meriki, Neama, Albeirouti, Bassem, Alqasmi, Amal, AlBalwi, Mohammed, Makhseed, Nawal, Hassan, Saeed, Shaheen, Marwan, Sermin, Saadeh, Shahrukh, Shamsad, Hashmi, Shahrukh, Shawli, Ayman, Tamim, Abdullah, Alnahari, Ahmed, Ghemlas, Ibrahim, Hussein, Maged, Wali, Sami, Murad, Hatem, Alkuraya, Fowzan S.

“…We report the results of clinical exome sequencing (CES) on >2,200 previously unpublished Saudi families as a first-tier test. The predominance of…”
Get full text

Higher Relapse Rate and Resource Utilization With Ara-C Consolidation Chemotherapy Alone Compared With Hematopoietic Cell Transplantation in First Remission in a Cohort of Younger Adults With Acute Myeloid Leukemia With t(8;21) (q22;q22 .1) by Alahmadi, Ahmed, Nasiri, Abdulrhman, Osman Ahmed, Syed, Aljurf, Mahmoud, Almohareb, Fahad

Get full text

AML-390 Higher Relapse Rate and Resource Utilization With Ara-C Consolidation Chemotherapy Alone Compared With Hematopoietic Cell Transplantation in First Remission in a Cohort of Younger Adults With Acute Myeloid Leukemia With t(8;21) (q22;q22.1) by Alahmadi, Ahmed, Nasiri, Abdulrhman, Osman Ahmed, Syed, Aljurf, Mahmoud, Almohareb, Fahad

“…Acute myeloid leukemia (AML) with t(8; 21) is classified as a favorable risk subtype, and high-dose Ara-C (HIDAC) consolidation is the recommended…”
Get full text

Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience by Alasbali, Reem, Alzahrani, Mohsen, Alhayli, Saud, Rasheed, Walid, Akhom, Phavina, Wilkerson, Karina, Essa, Mohammed, Elfakih, Riad, Alahmari, Bader, Samarkandi, Hadeel, Ahmed, Syed Osman, Saad, Ayman, Alzahrani, Hazza A., Almohareb, Fahad, Aljurf, Mahmoud, Kassim, Adetola A., Alahmari, Ali D

“…Introduction: The validated curative treatment for sickle cell disease (SCD) is allogeneic hematopoietic stem-cell transplantation (HSCT). Despite paucity of…”
Get full text

Lung transplantation for pulmonary graft versus host disease: experience from a referral organ transplantation center by El Fakih, Riad, Abdulqawi, Rayid, Bugnah, Amer, Arabi, Tarek Ziad, Rasheed, Walid, Ezzat, Loui, Shaheen, Marwan, Chaudhri, Naeem, Almohareb, Fahad, Al-Mutairy, Eid A., Aljurf, Mahmoud

Get full text

An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease by Kassim, Adetola A., de la Fuente, Josu, Nur, Erfan, Wilkerson, Karina L., Alahmari, Ali D., Seber, Adriana, Bonfim, Carmem, Simões, Belinda Pinto, Alzahrani, Mohsen, Eckrich, Michael J., Horn, Biljana, Hanna, Rabi, Dhedin, Nathalie, Rangarajan, Hemalatha G., Gouveia, Roseane Vasconcelos, Almohareb, Fahad, Aljurf, Mahmoud, Essa, Mohammed, Alahmari, Bader, Gatwood, Katie, Connelly, James A., Dovern, Elisabeth, Rodeghier, Mark, DeBaun, Michael R.

“…•For most adults with sickle cell disease, haploidentical BMT with thiotepa + PTCy is now a widely available curative option with excellent outcomes.•For…”
Get full text